Stanley Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.2M | Buy |
72,819
+14,300
| +24% | +$5.3M | 3.73% | 6 |
|
|
2026
Q1 | $17.1M | Hold |
58,519
| – | – | 2.86% | 14 |
|
|
2025
Q4 | $20.5M | Hold |
58,519
| – | – | 3.43% | 9 |
|
|
2025
Q3 | $18.9M | Buy |
58,519
+4,400
| +8% | +$1.37M | 3.11% | 11 |
|
|
2025
Q2 | $21.1M | Sell |
54,119
-9,000
| -14% | -$3.62M | 3.54% | 8 |
|
|
2025
Q1 | $27.5M | Hold |
63,119
| – | – | 5.4% | 2 |
|
|
2024
Q4 | $23.3M | Buy |
63,119
+21,019
| +50% | +$8.8M | 4.53% | 5 |
|
|
2024
Q3 | $21.9M | Hold |
42,100
| – | – | 4.25% | 5 |
|
|
2024
Q2 | $22.8M | Hold |
42,100
| – | – | 4.66% | 5 |
|
|
2024
Q1 | $21.8M | Buy |
42,100
+5,000
| +13% | +$2.49M | 5.43% | 5 |
|
|
2023
Q4 | $17.5M | Buy |
37,100
+4,000
| +12% | +$1.85M | 4.31% | 5 |
|
|
2023
Q3 | $14.4M | Hold |
33,100
| – | – | 3.84% | 6 |
|
|
2023
Q2 | $14.7M | Hold |
33,100
| – | – | 3.98% | 7 |
|
|
2023
Q1 | $15.2M | Hold |
33,100
| – | – | 4.54% | 4 |
|
|
2022
Q4 | $17M | Hold |
33,100
| – | – | 5.39% | 1 |
|
|
2022
Q3 | $15M | Hold |
33,100
| – | – | 5.2% | 1 |
|
|
2022
Q2 | $16M | Hold |
33,100
| – | – | 5.08% | 1 |
|
|
2022
Q1 | $16.3M | Buy |
33,100
+2,000
| +6% | +$914K | 4.74% | 2 |
|
|
2021
Q4 | $14.4M | Buy |
31,100
+1,000
| +3% | +$421K | 4.56% | 1 |
|
|
2021
Q3 | $11.2M | Buy |
30,100
+2,000
| +7% | +$760K | 4.13% | 1 |
|
|
2021
Q2 | $10.7M | Sell |
28,100
-1,000
| -3% | -$382K | 4.08% | 2 |
|
|
2021
Q1 | $10.4M | Buy |
29,100
+4,000
| +16% | +$1.29M | 4.16% | 2 |
|
|
2020
Q4 | $8.06M | Buy |
25,100
+1,000
| +4% | +$307K | 4.05% | 2 |
|
|
2020
Q3 | $6.47M | Buy |
24,100
+3,200
| +15% | +$861K | 4.49% | 1 |
|
|
2020
Q2 | $5.5M | Sell |
20,900
-8,000
| -28% | -$2.13M | 3.9% | 2 |
|
|
2020
Q1 | $6.56M | Sell |
28,900
-16,500
| -36% | -$4.5M | 5.06% | 4 |
|
|
2019
Q4 | $13.7M | Sell |
45,400
-1,700
| -4% | -$468K | 5.82% | 1 |
|
|
2019
Q3 | $11.3M | Buy |
47,100
+1,200
| +3% | +$329K | 5.53% | 2 |
|
|
2019
Q2 | $13M | Buy |
45,900
+5,300
| +13% | +$1.45M | 6.24% | 1 |
|
|
2019
Q1 | $11.7M | Sell |
40,600
-4,300
| -10% | -$1.24M | 5.7% | 2 |
|
|
2018
Q4 | $11.8M | Hold |
44,900
| – | – | 6.75% | 1 |
|
|
2018
Q3 | $12.3M | Sell |
44,900
-1,400
| -3% | -$363K | 5.77% | 1 |
|
|
2018
Q2 | $11M | Hold |
46,300
| – | – | 4.84% | 2 |
|
|
2018
Q1 | $10.2M | Buy |
46,300
+2,800
| +6% | +$658K | 4.6% | 1 |
|
|
2017
Q4 | $9.79M | Buy |
43,500
+3,500
| +9% | +$745K | 5.01% | 2 |
|
|
2017
Q3 | $7.59M | Hold |
40,000
| – | – | 4.24% | 6 |
|
|
2017
Q2 | $7.53M | Hold |
40,000
| – | – | 4.76% | 4 |
|
|
2017
Q1 | $6.62M | Buy |
40,000
+10,500
| +36% | +$1.67M | 4.12% | 6 |
|
|
2016
Q4 | $4.24M | Hold |
29,500
| – | – | 2.91% | 14 |
|
|
2016
Q3 | $3.7M | Buy |
29,500
+10,000
| +51% | +$1.29M | 2.92% | 14 |
|
|
2016
Q2 | $2.56M | Buy |
+19,500
| New | +$2.67M | 2.58% | 23 |
|
Other funds holding ELV
Stanley Capital Management's ELV Position: Q2 2026 in Review
Stanley Capital Management increased its Elevance Health (ELV) stake by 24% in Q2 2026, buying an estimated $5.3M and bringing the position to 72,819 shares worth $28.2M. The position accounts for 3.73% of the portfolio, ranked #6.
Stanley Capital Management first reported a position in ELV in Q2 2016 and has held it in 41 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Stanley Capital Management held 72,819 shares of Elevance Health worth $28.2M as of Q2 2026.
- Stanley Capital Management bought 14,300 Elevance Health shares in Q2 2026, an estimated $5.3M.
- Elevance Health made up 3.73% of Stanley Capital Management's portfolio in Q2 2026, its #6 holding.
- Stanley Capital Management first reported a position in Elevance Health in Q2 2016 and has held it in 41 quarters since.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Stanley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.